| DENALI THERAPEUTICS |
| USA |
| Gesundheit |
| US24823R1059 / A2H9G8 |
| 4DN (Frankfurt) / DNLI (NASDAQ) |
| FRA:4DN, ETR:4DN, 4DN:GR, NASDAQ:DNLI |
| - |
| https://denalitherapeutic.. |
|
Denali Therapeutics Inc. is a biopharmaceutical company focused on discovering and developing therapeutics to address neurodegenerative and lysosomal storage diseases. The company engineers product candidates using proprietary technologies such as An..
>Volltext.. |
| 2572.32 Mio. EUR |
| 1751.75 Mio. EUR |
| - |
| -460.06 Mio. EUR |
| -437.27 Mio. EUR |
| -2.48 EUR |
| 34.47 Mio. EUR |
| 333.64 Mio. EUR |
| - |
| 8.97 |
| - |
| -4.79% |
| - |
| - |
| - |
| - |
| DENALI THERAPEUTICS, DENALI THERAPEUTIC |
| 22.05.26 |
|